Add-on therapy with acetylcholinesterase inhibitors for memory dysfunction in schizophrenia: a systematic quantitative review, part 2.
about
Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.The Item-Specific Deficit Approach to evaluating verbal memory dysfunction: rationale, psychometrics, and applicationA 12-week open-label pilot study of donepezil for cognitive functioning and instrumental activities of daily living in late-life bipolar disorder.Translational Aspects of the Novel Object Recognition Task in Rats Abstinent Following Sub-Chronic Treatment with Phencyclidine (PCP): Effects of Modafinil and Relevance to Cognitive Deficits in SchizophreniaEffectiveness of rivastigmine on positive, negative, and cognitive symptoms of schizophrenia: a double-blind clinical trial.Cognitive effects with rivastigmine augmentation of risperidone: A 12-month, randomized, double-blind, placebo-controlled study in schizophrenia.
P2860
Add-on therapy with acetylcholinesterase inhibitors for memory dysfunction in schizophrenia: a systematic quantitative review, part 2.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Add-on therapy with acetylchol ...... c quantitative review, part 2.
@en
type
label
Add-on therapy with acetylchol ...... c quantitative review, part 2.
@en
prefLabel
Add-on therapy with acetylchol ...... c quantitative review, part 2.
@en
P1476
Add-on therapy with acetylchol ...... c quantitative review, part 2.
@en
P2093
Sylvie Chouinard
P304
P356
10.1097/WNF.0B013E318059BE76
P577
2007-07-01T00:00:00Z